Specialty biopharmaceutical company can easily organize, assign, and track training for improved audit-readiness and compliance The addition of Vault Training builds upon the company's success with ...
Complete and connected solution for documents, learning, and accredited training content transforms role-based qualification PLEASANTON, Calif., June 2, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV ...
PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE:VEEV) today announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help ...
Veeva Vault Study Training unifies learning management and clinical operations for integrated and automated training and real-time inspection readiness PLEASANTON, Calif., June 7, 2022 /PRNewswire/ -- ...
Veeva Systems VEEV recently announced the availability of Vault Basics, a new offering that includes technology, training, and support designed for biotechs. Vault Basics enables rapidly expanding ...
BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE:VEEV) today announced that Alvotech, a biopharmaceutical company specializing in biosimilars, adopted Veeva Vault Training for more effective ...
Complete and connected solution for documents, learning, and accredited training content transforms role-based qualification "Having a modern LMS that provides visibility into training status, ...
PLEASANTON, Calif., June 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Study Training, a new application that brings together research sites, CROs, and sponsors into a ...
Complete and connected solution for documents, learning, and accredited training content transforms role-based qualification PLEASANTON, Calif., June 2, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ...
PLEASANTON, Calif., June 2, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 organizations are using Veeva Vault Training for unified role-based training and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results